Vol 14, No 4 (2018)
Guidelines / Expert consensus
Published online: 2018-04-23
Nutritional treatment
DOI: 10.5603/OCP.2018.0028
Oncol Clin Pract 2018;14(4):216-225.
Abstract
Not available
References
- Sobotka L. Podstawy żywienia klinicznego. Krakowskie Wydawnictwo Scientifica, Kraków 2014.
- Krzemieniecki K. Leczenie wyniszczenia nowotworowego – dobrodziejstwo dla chorych a przekleństwo dla NFZ?Krytyczna analiza zjawiska terapii wyniszczenia nowotworowego w Polsce;. Współczesna Onkologia. 2008; 12(1): 38–42.
- Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011; 12(5): 489–495.
- Góraj E. Ocena stadium zaawansowania wyniszczenia nowotworowego w momencie rozpoznania oraz jakościowa i ilościowa analiza zastosowanego leczenia wyniszczenia u chorych leczonych onkologicznie, Raport podsumowujący. http://www.moneopharma.pl/img/WN-ONK-13-Raport-Koncowy.pdf (2014).
- Grabiec K, Burchert M, Milewska M, et al. Systemic and local mechanisms leading to cachexia in cancer. Postępy Higieny i Medycyny Doświadczalnej. 2013; 67: 1397–1409.
- Andreyev HJ, Norman AR, Oates J, et al. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer. 1998; 34(4): 503–509.
- Dewys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med. 1980; 69(4): 491–497.
- Berclaz G. Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Annals of Oncology. 2004; 15(6): 875–884.
- Manilich E, Vogel JD, Kiran RP, et al. Key factors associated with postoperative complications in patients undergoing colorectal surgery. Dis Colon Rectum. 2013; 56(1): 64–71.
- Arrieta O, Michel Ortega RM, Villanueva-Rodríguez G, et al. Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study. BMC Cancer. 2010; 10: 50.
- Hofman M, Ryan JL, Figueroa-Moseley CD, et al. Cancer-Related Fatigue: The Scale of the Problem. The Oncologist. 2007; 12(suppl_1): 4–10.
- von Haehling S, Anker SD. Cachexia as a major underestimated and unmet medical need: facts and numbers. J Cachexia Sarcopenia Muscle. 2010; 1(1): 1–5.
- Nipp RD, Greer JA, El-Jawahri A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010; 363(8): 733–742.
- Aapro M, Arends J, Bozzetti F, et al. ESMO (European School of Medical Oncology). Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task Force. Ann Oncol. 2014; 25(8): 1492–1499.
- Maddocks M, Murton AJ, Wilcock A. Therapeutic exercise in cancer cachexia. Crit Rev Oncog. 2012; 17(3): 285–292.
- Ries A, Trottenberg P, Elsner F, et al. A systematic review on the role of fish oil for the treatment of cachexia in advanced cancer: an EPCRC cachexia guidelines project. Palliat Med. 2012; 26(4): 294–304.
- Solheim TS, Fearon KCH, Blum D, et al. Non-steroidal anti-inflammatory treatment in cancer cachexia: a systematic literature review. Acta Oncol. 2013; 52(1): 6–17.
- Isenring EA, Capra S, Bauer JD, et al. The impact of nutrition support on body composition in cancer outpatients receiving radiotherapy. Acta Diabetol. 2003; 40 Suppl 1(3): S162–S164.
- Mantovani G, Macció A, Bianchi A, et al. Megestrol acetate in neoplastic anorexia/cachexia: clinical evaluation and comparison with cytokine levels in patients with head and neck carcinoma treated with neoadjuvant chemotherapy. International Journal of Clinical and Laboratory Research. 1995; 25(3): 135–141.
- McQuellon R, Moose D, Russell G, et al. Supportive use of megestrol acetate (Megace) with head/neck and lung cancer patients receiving radiation therapy. International Journal of Radiation Oncology*Biology*Physics. 2002; 52(5): 1180–1185.
- Lundholm K, Gelin J, Hyltander A, et al. Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors. Cancer Res. 1994; 54(21): 5602–5606.
- McMillan DC, Wigmore SJ, Fearon KC, et al. A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss. Br J Cancer. 1999; 79(3-4): 495–500.
- Zang J, Hou M, Gou HF, et al. Antiemetic activity of megestrol acetate in patients receiving chemotherapy. Support Care Cancer. 2011; 19(5): 667–673.
- Zhan P, Wang Q, Qian Q, et al. Megestrol acetate in cancer patients with anorexia-cachexia syndrome: a meta-analysis. Transl Cancer Res. 2013; 2(2): 74–79.